486 related articles for article (PubMed ID: 30173862)
1. Reprint of: A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies.
Shah UK; Mallia JO; Singh N; Chapman KE; Doak SH; Jenkins GJS
Mutat Res Genet Toxicol Environ Mutagen; 2018 Oct; 834():35-41. PubMed ID: 30173862
[TBL] [Abstract][Full Text] [Related]
2. A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies.
Shah UK; Mallia JO; Singh N; Chapman KE; Doak SH; Jenkins GJS
Mutat Res Genet Toxicol Environ Mutagen; 2018 Jan; 825():51-58. PubMed ID: 29307375
[TBL] [Abstract][Full Text] [Related]
3. Detection of urethane-induced genotoxicity in vitro using metabolically competent human 2D and 3D spheroid culture models.
Shah UK; Verma JR; Chapman KE; Wilde EC; Tonkin JA; Brown MR; Johnson GE; Doak SH; Jenkins GJ
Mutagenesis; 2020 Dec; 35(6):445-452. PubMed ID: 33219664
[TBL] [Abstract][Full Text] [Related]
4. Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations.
Conway GE; Shah UK; Llewellyn S; Cervena T; Evans SJ; Al Ali AS; Jenkins GJ; Clift MJD; Doak SH
Mutagenesis; 2020 Sep; 35(4):319-330. PubMed ID: 32780103
[TBL] [Abstract][Full Text] [Related]
5. CYP1A1 and CYP1A2 expression levels are differentially regulated in three-dimensional spheroids of liver cancer cells compared to two-dimensional monolayer cultures.
Terashima J; Goto S; Hattori H; Hoshi S; Ushirokawa M; Kudo K; Habano W; Ozawa S
Drug Metab Pharmacokinet; 2015 Dec; 30(6):434-40. PubMed ID: 26643992
[TBL] [Abstract][Full Text] [Related]
6. Development of in vitro 3D cell model from hepatocellular carcinoma (HepG2) cell line and its application for genotoxicity testing.
Štampar M; Tomc J; Filipič M; Žegura B
Arch Toxicol; 2019 Nov; 93(11):3321-3333. PubMed ID: 31542801
[TBL] [Abstract][Full Text] [Related]
7. High-throughput micronucleus assay using three-dimensional HepaRG spheroids for in vitro genotoxicity testing.
Seo JE; Li X; Le Y; Mei N; Zhou T; Guo X
Arch Toxicol; 2023 Apr; 97(4):1163-1175. PubMed ID: 36847820
[TBL] [Abstract][Full Text] [Related]
8. Characterization and reproducibility of HepG2 hanging drop spheroids toxicology in vitro.
Hurrell T; Ellero AA; Masso ZF; Cromarty AD
Toxicol In Vitro; 2018 Aug; 50():86-94. PubMed ID: 29476884
[TBL] [Abstract][Full Text] [Related]
9. 3D spheroid cultures improve the metabolic gene expression profiles of HepaRG cells.
Takahashi Y; Hori Y; Yamamoto T; Urashima T; Ohara Y; Tanaka H
Biosci Rep; 2015 May; 35(3):. PubMed ID: 26182370
[TBL] [Abstract][Full Text] [Related]
10. Application of HepG2/C3A liver spheroids as a model system for genotoxicity studies.
Coltman NJ; Coke BA; Chatzi K; Shepherd EL; Lalor PF; Schulz-Utermoehl T; Hodges NJ
Toxicol Lett; 2021 Jul; 345():34-45. PubMed ID: 33865918
[TBL] [Abstract][Full Text] [Related]
11. Optimization of Albumin Secretion and Metabolic Activity of Cytochrome P450 1A1 of Human Hepatoblastoma HepG2 Cells in Multicellular Spheroids by Controlling Spheroid Size.
Nishikawa T; Tanaka Y; Nishikawa M; Ogino Y; Kusamori K; Mizuno N; Mizukami Y; Shimizu K; Konishi S; Takahashi Y; Takakura Y
Biol Pharm Bull; 2017; 40(3):334-338. PubMed ID: 28250275
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the genotoxicity of benzo[a]pyrene in four cell lines with differing metabolic capacity.
Shah UK; Seager AL; Fowler P; Doak SH; Johnson GE; Scott SJ; Scott AD; Jenkins GJ
Mutat Res Genet Toxicol Environ Mutagen; 2016 Sep; 808():8-19. PubMed ID: 27637481
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an in vitro three-dimensional HepaRG spheroid model for genotoxicity testing using the high-throughput CometChip platform.
Seo JE; He X; Muskhelishvili L; Malhi P; Mei N; Manjanatha M; Bryant M; Zhou T; Robison T; Guo X
ALTEX; 2022; 39(4):583-604. PubMed ID: 35791290
[TBL] [Abstract][Full Text] [Related]
14. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies.
Ramaiahgari SC; den Braver MW; Herpers B; Terpstra V; Commandeur JN; van de Water B; Price LS
Arch Toxicol; 2014 May; 88(5):1083-95. PubMed ID: 24599296
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing.
Seo JE; Le Y; Revollo J; Miranda-Colon J; Xu H; McKinzie P; Mei N; Chen T; Heflich RH; Zhou T; Robison T; Bonzo JA; Guo X
Arch Toxicol; 2024 Jun; 98(6):1919-1935. PubMed ID: 38584193
[TBL] [Abstract][Full Text] [Related]
16. The comet assay applied to HepG2 liver spheroids.
Elje E; Hesler M; Rundén-Pran E; Mann P; Mariussen E; Wagner S; Dusinska M; Kohl Y
Mutat Res Genet Toxicol Environ Mutagen; 2019 Sep; 845():403033. PubMed ID: 31561895
[TBL] [Abstract][Full Text] [Related]
17. Ready to go 3D? A semi-automated protocol for microwell spheroid arrays to increase scalability and throughput of 3D cell culture testing.
Basu A; Dydowiczová A; Trosko JE; Bláha L; Babica P
Toxicol Mech Methods; 2020 Oct; 30(8):590-604. PubMed ID: 32713235
[TBL] [Abstract][Full Text] [Related]
18. High-throughput confocal imaging of differentiated 3D liver-like spheroid cellular stress response reporters for identification of drug-induced liver injury liability.
Hiemstra S; Ramaiahgari SC; Wink S; Callegaro G; Coonen M; Meerman J; Jennen D; van den Nieuwendijk K; Dankers A; Snoeys J; de Bont H; Price L; van de Water B
Arch Toxicol; 2019 Oct; 93(10):2895-2911. PubMed ID: 31552476
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma (HepG2/C3A) cell-based 3D model for genotoxicity testing of chemicals.
Štampar M; Sedighi Frandsen H; Rogowska-Wrzesinska A; Wrzesinski K; Filipič M; Žegura B
Sci Total Environ; 2021 Feb; 755(Pt 2):143255. PubMed ID: 33187710
[TBL] [Abstract][Full Text] [Related]
20. Formation of stable small cell number three-dimensional ovarian cancer spheroids using hanging drop arrays for preclinical drug sensitivity assays.
Raghavan S; Ward MR; Rowley KR; Wold RM; Takayama S; Buckanovich RJ; Mehta G
Gynecol Oncol; 2015 Jul; 138(1):181-9. PubMed ID: 25913133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
